| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |